Forge Therapeutics Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 13
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $11.1M
Latest Deal Amount
  • Investors
  • 15

Forge Therapeutics General Information

Description

Developer of novel antibiotics intended to treat multi-drug resistant bacteria. The company's platform develops small molecule inhibitors targeting metalloenzymes using gram-negative bacteria, enabling healthcare professionals to access various biochemical processes and biological catalysis to treat diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 10578 Science Center Drive
  • Suite 205
  • San Diego, CA 92121
  • United States

Forge Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Forge Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 03-Jan-2019 $11.1M 000.00 Completed Pre-Clinical Trials
4. Early Stage VC (Series A) 01-Dec-2017 000.00 000.00 Completed Pre-Clinical Trials
3. Grant 26-Jul-2016 00.00 Completed Pre-Clinical Trials
2. Grant 01-Jan-2016 $150K Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2015 Completed Pre-Clinical Trials
To view Forge Therapeutics’s complete valuation and funding history, request access »

Forge Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Forge Therapeutics’s complete cap table history, request access »

Forge Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel antibiotics intended to treat multi-drug resistant bacteria. The company's platform develops small mo
Drug Discovery
San Diego, CA
13 As of 2021
000.00
0000000000 000.00

00000 00

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqu
0000000000000
Cambridge, MA
00 As of 0000
00000
000000 - 000 00000

0000000

enderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupi
0000 000000000
Boston, MA
0 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Forge Therapeutics Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Spero Therapeutics Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
0000000 0000000000 Venture Capital-Backed Boston, MA 0 000.00 00000000000 000.00
000000000 Venture Capital-Backed Basel, Switzerland 00 000.00 000000000 000.00
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
0000000000 0000000 Formerly VC-backed Watertown, MA 00 00000 000000&0 00000
You’re viewing 5 of 9 competitors. Get the full list »

Forge Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Zachary Zimmerman Ph.D Co-Founder, Chief Executive Officer & Board Member
David Puerta Ph.D Co-Founder, Chief Operating Officer & Vice President of Discovery
Esther van den Boom Chief Financial Officer
Seth Cohen Ph.D Scientific Co-Founder & Advisor
You’re viewing 4 of 5 executive team members. Get the full list »

Forge Therapeutics Board Members (7)

Name Representing Role Since
Brian Dorsey Self Board Member 000 0000
Jeffrey Moore Ph.D MP Healthcare Venture Management Board Observer 000 0000
John Schmid Self Board Member 000 0000
Jonathan Kabakoff Alexandria Venture Investments Board Observer 000 0000
Mario Polywka Ph.D Evotec Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Forge Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Forge Therapeutics Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Bernard Rudnick Angel (individual) Minority 000 0000 000000 0
Evotec Corporation Minority 000 0000 000000 0
Keiretsu Capital Venture Capital Minority 000 0000 000000 0
MagnaSci Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »